PAMCX | PMVRX | PAMCX / PMVRX | |
Total Expense Ratio | 1.01 | 1.30 | 78% |
Annual Report Gross Expense Ratio | 1.01 | 1.30 | 78% |
Fund Existence | 26 years | 23 years | - |
Gain YTD | 2.427 | 3.537 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 26.9B | 374M | 7,193% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -7.39 | -9.04 | 82% |
Returns for 3 years | 20.13 | 36.92 | 55% |
Returns for 5 years | 0.69 | -13.17 | -5% |
Returns for 10 years | 31.58 | 12.94 | 244% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GOAU | 39.33 | 0.87 | +2.27% |
US Global GO GOLD and Prec Mtl Mnrs ETF | |||
SMDV | 66.75 | 0.58 | +0.87% |
ProShares Russell 2000 Dividend Growers | |||
QLD | 135.31 | 1.08 | +0.80% |
ProShares Ultra QQQ | |||
AZTD | 28.98 | N/A | N/A |
Aztlan Global Stock Sel Dm SMID ETF | |||
LFSC | 29.36 | N/A | N/A |
F/m Emerald Life Sciences Innovation ETF |